[Experimental study of relationship between effect of ginsenoside Rg1 to delay hematopoietic stem cell senescence and expression of p16(INK4a)].

Jun 11, 2011Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Ginsenoside Rg1 may delay blood stem cell aging by affecting p16(INK4a) levels

AI simplified

Abstract

Ginsenoside Rg1 may significantly delay hematopoietic stem cell senescence, as indicated by changes in cellular markers.

  • The percentage of cells expressing senescence-associated beta-galactosidase decreased in groups treated with Rg1 compared to the aging group.
  • Cells in the G1 phase of the cell cycle were reduced in Rg1 treat and Rg1 delay aging groups relative to the aging group.
  • The number of mixed hematopoietic progenitor colonies increased in Rg1 treat and Rg1 delay aging groups when compared to the aging group.
  • Higher levels of p16(INK4a) mRNA and protein expression were observed in the Rg1 treat aging group and Rg1 delay aging group compared to the aging group.
  • The Rg1 delay aging group showed further decreases in senescence markers and p16(INK4a) levels compared to the Rg1 treat aging group.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free